Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

Abstract Hypothyroidism is a risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD) but it is not clear whether subclinical hypothyroidism (SCH) increases the risk of MASLD and whether SCH patients with MASLD require treatment. In this study, we reviewed articles published...

Celý popis

Podrobná bibliografie
Hlavní autoři: Sicheng Pu, Binbin Zhao, Yuxuan Jiang, Xuejiao Cui
Médium: Článek
Jazyk:English
Vydáno: BMC 2025-02-01
Edice:Lipids in Health and Disease
Témata:
Hypothyroidism
Subclinical hypothyroidism
Non-alcoholic fatty liver disease
Metabolic dysfunction-associated steatotic liver disease
Molecular roles
Thyroid-related medication
On-line přístup:https://doi.org/10.1186/s12944-025-02474-0

Internet

https://doi.org/10.1186/s12944-025-02474-0

Podobné jednotky